ArticleJournal of neurochemistry2020

A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for "Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer"on page 486.

Lawrence SteinmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.